Literature DB >> 7240192

Reversible methylation of cytoskeletal and membrane proteins in intact human erythrocytes.

C Freitag, S Clarke.   

Abstract

Membrane protein methylation was studied in intact human erythrocytes. Erythrocytes were incubated with physiological concentrations of L-[methyl]3H]methionine and incorporated 35 pmol of methyl groups into membrane components/mg of membrane protein in a 2.5-hr incubation at 37 degrees C. At least 90% of the total groups (12,500 methyl groups/cell) were incorporated into polypeptides via linkages which were labile to 1 N NaOH. Major methylated membrane polypeptides were identified based on the comigration of radioactivity with Coomassie blue- and periodic acid-Schiff-staining species in pH 2.4 dodecyl sulfate gel electrophoresis, as well as by the distribution of radiolabel and protein following selective proteolysis and membrane extraction procedures. Methylated species identified in this way include the cytoskeletal polypeptides band 2.1 (ankyrin) and band 4.1, as well as the band 3 anion transport protein. Other methylated species include an intrinsic polypeptide comigrating with band 3 but insensitive to external chymotrypsin digestion, a glycoprotein showing variable migration in this gel system (40,000-55,000 daltons), an intrinsic polypeptide at about 30,000 daltons, and an extrinsic species of about 17,000 daltons. A small amount of radioactivity comigrated with the band 4.5 region. Bands 1, 2, 4.2, 5, 6, 7, and the major sialoglycoprotein were not methylated in this system. All of the methylated species exhibited turnover in vivo, and the time taken to reach 50% demethylation for each species ranged from less than 2 to 29 h.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7240192

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Deficiency of a protein-repair enzyme results in the accumulation of altered proteins, retardation of growth, and fatal seizures in mice.

Authors:  E Kim; J D Lowenson; D C MacLaren; S Clarke; S G Young
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

2.  Carboxyl methylation of human erythrocyte band 3 in intact cells. Relation to anion transport activity.

Authors:  L L Lou; S Clarke
Journal:  Biochem J       Date:  1986-04-01       Impact factor: 3.857

Review 3.  Protein damage and methylation-mediated repair in the erythrocyte.

Authors:  P Galletti; D Ingrosso; C Manna; G Clemente; V Zappia
Journal:  Biochem J       Date:  1995-03-01       Impact factor: 3.857

4.  Methylation at D-aspartyl residues in erythrocytes: possible step in the repair of aged membrane proteins.

Authors:  P N McFadden; S Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

5.  Conversion of isoaspartyl peptides to normal peptides: implications for the cellular repair of damaged proteins.

Authors:  P N McFadden; S Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

6.  Membrane skeletal alterations during in vivo mouse red cell aging. Increase in the band 4.1a:4.1b ratio.

Authors:  T J Mueller; C W Jackson; M E Dockter; M Morrison
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

7.  Differential membrane protein carboxyl-methylation of intact human erythrocytes by exogenous methyl donors.

Authors:  J Y Ro; P DiMaria; S Kim
Journal:  Biochem J       Date:  1984-05-01       Impact factor: 3.857

8.  Stoichiometric methylation of calcineurin by protein carboxyl O-methyltransferase and its effects on calmodulin-stimulated phosphatase activity.

Authors:  M L Billingsley; R L Kincaid; W Lovenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

9.  Enzymatic methyl esterification of erythrocyte membrane proteins is impaired in chronic renal failure. Evidence for high levels of the natural inhibitor S-adenosylhomocysteine.

Authors:  A F Perna; D Ingrosso; V Zappia; P Galletti; G Capasso; N G De Santo
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.